Nitric oxide mediated endothelium-dependent relaxation induced by glibenclamide in rat isolated aorta

被引:32
作者
Chan, WK [1 ]
Yao, XQ [1 ]
Ko, WH [1 ]
Huang, Y [1 ]
机构
[1] Chinese Univ Hong Kong, Fac Med, Dept Physiol, Shatin, Hong Kong, Peoples R China
关键词
arteries; Ca-channel; endothelial function; K-ATP channel; nitric oxide; vasoconstriction/dilation;
D O I
10.1016/S0008-6363(99)00423-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glibenclamide was found to act as both a selective ATP-sensitive K- channel blocker and a vasorelaxant. The exact mechanisms underlying the relaxant effect of glibenclamide are unknown. The present study was designed to examine the role of endothelium/nitric oxide in glibenclamide-induced relaxation in rot isolated aortic rings. Methods: A combination of experimental approaches including isometric force measurement, cell culture. Ca2+ fluorescence measurement and radioimmunoassay were used to examine the vascular effect of glibenclamide. Results: Glibenclamide induced a concentration-dependent relaxation mon effectively in rings with endothelium (IC50 of 32+/-4 mu M) than those without endothelium (IC50 of 365+/-29 mu M). incubation with N-G-nitro-L-arginine methyl ester (L-NAME) or methylene blue significantly reduced and L-arginine (3 mM) potentiated the glibenelamide-induced relaxation. L-Arginine (3 mM) partially antagonized the effect of L-NAME. Glibenclamide (100 mu M) increased the cyclic GMP content of endothelium-intact tissues. Pretreatment with N-G-nitro-L-arginine (100 mu M) or removal of endothelium significantly suppressed the effect of glibenclamide on cyclic GMP production. Glibenclamide elevated the intracellular Ca2+ levels in cultured rat aortic endothelial cells. Glibenclamide also inhibited the endothelium-independent contractile response to 60 mM K+ (IC50 of 137+/-21 mu M) and caused a rightward shift in the concentration-contraction curve for CaCl2. Besides, glibenclamide inhibited phorbul- 12,13-diacetate (1 mu M)-induced contraction in Ca2+-free Krebs solution. Conclusion: These results indicate that glibenclamide-induced endothelium-dependent relaxation involves nitric elude release and this effect may be related to its stimulatory effect on endothelial Ca2+ levels. However. the glibenclamide-induced endothelium-independent relaxation may be associated with its inhibitory effect on Ca2+ influx through Ca2+ channels and on the protein kinase C-mediated contractile mechanism. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:180 / 187
页数:8
相关论文
共 26 条
  • [1] PROPERTIES AND FUNCTIONS OF ATP-SENSITIVE K-CHANNELS
    ASHCROFT, SJH
    ASHCROFT, FM
    [J]. CELLULAR SIGNALLING, 1990, 2 (03) : 197 - 214
  • [2] ADENOSINE-5'-TRIPHOSPHATE-SENSITIVE ION CHANNELS IN NEONATAL RAT CULTURED CENTRAL NEURONS
    ASHFORD, MLJ
    STURGESS, NC
    TROUT, NJ
    GARDNER, NJ
    HALES, CN
    [J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1988, 412 (03): : 297 - 304
  • [3] GLIBENCLAMIDE IS A COMPETITIVE ANTAGONIST OF THE THROMBOXANE A2 RECEPTOR IN DOG CORONARY-ARTERY INVITRO
    COCKS, TM
    KING, SJ
    ANGUS, JA
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1990, 100 (02) : 375 - 378
  • [4] PROSTANOID-INDUCED CONTRACTIONS ARE BLOCKED BY SULFONYLUREAS
    DELAEY, C
    VANDEVOORDE, J
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 280 (02) : 179 - 184
  • [5] Heterogeneity of the inhibitory influence of sulfonylureas on prostanoid-induced smooth muscle contraction
    Delaey, C
    VandeVoorde, J
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 325 (01) : 41 - 46
  • [6] Huang Y, 1996, J CELL PHYSIOL, V168, P678, DOI 10.1002/(SICI)1097-4652(199609)168:3<678::AID-JCP20>3.0.CO
  • [7] 2-U
  • [8] Contribution of nitric oxide and K+ channel activation to vasorelaxation of isolated rat aorta induced by procaine
    Huang, Y
    Lau, CW
    Chan, FL
    Yao, XQ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 367 (2-3) : 231 - 237
  • [9] Involvement of endothelium in relaxant action of glibenclamide on the rat mesenteric artery
    Huang, Y
    Chan, NKWK
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 343 (01) : 27 - 33
  • [10] IGNARRO LJ, 1984, J PHARMACOL EXP THER, V228, P682